Biocompatibility of icodextrin.
暂无分享,去创建一个
[1] O. Devuyst,et al. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. , 2002, Kidney international.
[2] Geraint T. Williams,et al. Morphologic changes in the peritoneal membrane of patients with renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[3] J. Wautier,et al. AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. , 2002, Kidney international.
[4] M. Kolb,et al. Gene Transfer of Transforming Growth Factor- 1 to the Rat Peritoneum: Effects on Membrane Function , 2001 .
[5] S. B. Kim,et al. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. , 2001, Kidney international.
[6] W. Reichel,et al. A Case of Sterile Peritonitis Associated with Icodextrin Solution , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[7] P. Heering,et al. Peritoneal Reaction to Icodextrin in a Female Patient on CAPD , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[8] K. Lai,et al. Expression of aquaporin-1 in human peritoneal mesothelial cells and its upregulation by glucose in vitro. , 2001, Journal of the American Society of Nephrology : JASN.
[9] R. Krediet,et al. Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. , 2001, Kidney international.
[10] A. Douvdevani,et al. CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. , 2001, Journal of the American Society of Nephrology : JASN.
[11] D. Marples. Aquaporins: Roles in Renal Function and Peritoneal Dialysis , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[12] U. Frei,et al. Glucose Degradation Products and Peritoneal Membrane Function , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[13] H. Ha,et al. High glucose–induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells , 2001 .
[14] A. Donker,et al. Amadori Albumin and Advanced Glycation End-Product Formation in Peritoneal Dialysis using Icodextrin , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[15] M. Ishida,et al. Hyperosmotic stimuli induces recruitment of aquaporin-1 to plasma membrane in cultured rat peritoneal mesothelial cells. , 2001, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[16] H. Kang,et al. Effects of Conventional and New Peritoneal Dialysis Solutions on Human Peritoneal Mesothelial Cell Viability and Proliferation , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[17] T. Miyata,et al. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids. , 2000, Kidney international.
[18] P. Stenvinkel,et al. Biocompatibility of New Peritoneal Dialysis Solutions: What Can We Hope to Achieve? , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[19] L. Gotloib,et al. High glucose accelerates the life cycle of the in vivo exposed mesothelium. , 2000, Kidney international.
[20] R. Selgas,et al. Icodextrin Effluent Leads to a Greater Proliferation than Glucose Effluent of Human Mesothelial Cells Studied Ex Vivo , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[21] K. Nolph,et al. Advanced Glycosylation End-Products in Diabetic Rats on Peritoneal Dialysis Using Various Solutions , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[22] N. Yorioka,et al. Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. , 2000, Journal of the American Society of Nephrology : JASN.
[23] R. Gokal. Newer peritoneal dialysis solutions. , 2000, Advances in renal replacement therapy.
[24] M. Davies,et al. Production and Regulation of Matrix Metalloproteinases and Their Inhibitors by Human Peritoneal Mesothelial Cells , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[25] T. Miyata,et al. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. , 2000, Kidney international.
[26] M. Bonomini,et al. A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[27] L. Gotloib,et al. Effects of Osmotic Agents upon the in Vivo Exposed Mesothelial Monolayer , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[28] C. Holmes,et al. Strategies to Reduce Glucose Exposure in Peritoneal Dialysis Patients , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[29] O. Devuyst,et al. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. , 2000, Journal of the American Society of Nephrology : JASN.
[30] U. Frei,et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. , 2000, Journal of the American Society of Nephrology : JASN.
[31] A. Donker,et al. Peritoneal Kinetics and Mesothelial Markers in CCPD Using Icodextrin for Daytime Dwell for Two Years , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[32] T. Kooistra,et al. D-glucose Increases the Synthesis of Tissue-type Plasminogen Activator (t-PA) in Human Peritoneal Mesothelial Cells , 1999, Thrombosis and Haemostasis.
[33] G. D'Amico,et al. Recurrent Sterile Peritonitis at Onset of Treatment with Icodextrin Solution , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[34] A. Donker,et al. Peritoneal Defense Using Icodextrin Or Glucose for Daytime Dwell in Ccpd Patients , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[35] K. Nitta,et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[36] W. Yang,et al. Interleukin-1β Stimulates the Production of Extracellular Matrix in Cultured Human Peritoneal Mesothelial Cells , 1999 .
[37] T. Tomo,et al. Maillard Reaction and Age Formation in Glucose and Polyglucose Dialysis Solutions , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[38] D. Kang,et al. High Glucose Solution and Spent Dialysate Stimulate the Synthesis of Transforming Growth Factor-β1 of Human Peritoneal Mesothelial Cells: Effect of Cytokine Costimulation , 1999 .
[39] T. Miyata,et al. Carbonyl Stress: Increased Carbonyl Modification of Proteins by Autoxidation Products of Carbohydrates and Lipids in Uremia , 1999, The International journal of artificial organs.
[40] P. Erhard,et al. Analysis of Non Enzymatic Glycosylation In Vivo: Impact of Different Dialysis Solutions , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[41] C van Ypersele de Strihou,et al. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. , 1999, Kidney international.
[42] C. Holmes,et al. Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro. , 1999, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[43] R. Krediet. The peritoneal membrane in chronic peritoneal dialysis. , 1999, Kidney international.
[44] T. Kooistra,et al. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. , 1999, Kidney international.
[45] N. Yorioka,et al. Advanced Glycation End-Products Reduce the Viability of Human Peritoneal Mesothelial Cells , 1998, Nephron.
[46] S. Mandl,et al. High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity. , 1998, Journal of the American Society of Nephrology : JASN.
[47] R. Vanholder,et al. Consequences of Using Glucose in Peritoneal Dialysis Fluid , 1998 .
[48] G. Sobue,et al. Accelerated formation of N epsilon-(carboxymethyl) lysine, an advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons. , 1998, Biochemical and biophysical research communications.
[49] B. Grabensee,et al. Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes. , 1998, Kidney international.
[50] T. Henle,et al. 3-Deoxyglucosone, a Promoter of Advanced Glycation end Products in Fluids for Peritoneal Dialysis , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[51] M. Kretzler,et al. Expression of glucose transporters in human peritoneal mesothelial cells. , 1998, Kidney international.
[52] R. Bucala,et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. , 1998, The Journal of clinical investigation.
[53] J. Moberly,et al. New developments in peritoneal dialysis solutions. , 1998, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.
[54] M. Davies,et al. Response of the human peritoneal mesothelial cell to injury: an in vitro model of peritoneal wound healing. , 1998, Kidney international.
[55] T. Watanabe,et al. Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. , 1997, Biochemical and biophysical research communications.
[56] J. Lin,et al. Absence of Modulating Effects of Cytokines on Antioxidant Enzymes in Peritoneal Mesothelial Cells , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[57] T. Mettang,et al. In vitro effects of glucose polymer-containing peritoneal dialysis fluids on phagocytic activity. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[58] D. Millar,et al. Glycation and Advanced Glycation End-Product Formation with Icodextrin and Dextrose , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[59] B. Risberg,et al. Plasminogen activators and inhibitors in peritoneal tissue , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[60] L. Henderson,et al. Impact of terminal heat sterilization on the quality of peritoneal dialysis solutions. , 1997, Blood purification.
[61] T. Shigematsu,et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. , 1997, Kidney international.
[62] Nagy Ja. Peritoneal membrane morphology and function. , 1996 .
[63] T. Kooistra,et al. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. , 1996, The American journal of physiology.
[64] M. Davies,et al. IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD. , 1996, Kidney international.
[65] N. Topley,et al. Macrophages and mesothelial cells in bacterial peritonitis. , 1996, Immunobiology.
[66] P. Klingler,et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. , 1996, The American journal of pathology.
[67] W. Luttmann,et al. Adherence of neutrophils to human peritoneal mesothelial cells: role of intercellular adhesion molecule-1. , 1996, Journal of the American Society of Nephrology : JASN.
[68] A. Wieslander,et al. Glucose Degradation and Cytotoxicity in Pd Fluids , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[69] J. Hjelle,et al. Effects of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells. , 1996, Blood purification.
[70] G. Sozzi,et al. Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement. , 1996, Cytogenetics and cell genetics.
[71] K. Nitta,et al. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. , 1996, Nephron.
[72] H. Verbrugh,et al. First -Line Defense Mechanisms in the Peritoneal Cavity during Peritoneal Dialysis , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[73] M. Shimoda,et al. The Role of Tgf-β in Growth Inhibition of Peritoneal Mesothelial Cells in High-Glucose Dialysate , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[74] A. Wieslander,et al. Are Aldehydes in Heat-Sterllized Peritoneal Dialysis Fluids Toxic in Vitro? , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[75] A. Dawnay,et al. In vitro formation of advanced glycation end products in peritoneal dialysis fluid. , 1995, Kidney international.
[76] N. Topley. The Host's Initial Response to Peritoneal Infection: The Pivotal Role of the Mesothelial Cell , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[77] E. Stylianou,et al. Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans. , 1995, The American journal of pathology.
[78] B. Holmquist,et al. Development of Toxic Degradation Products during Heat Sterilization of Glucose-Containing Fluids for Peritoneal Dialysis: Influence of Time and Temperature , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[79] Paul J Thornalley,et al. Formation of methylglyoxal-modified proteins in vitro and in vivo and their involvement in AGE-related processes. , 1995, Contributions to nephrology.
[80] C. Holmes. Peritoneal host defense mechanisms in peritoneal dialysis. , 1994, Kidney international. Supplement.
[81] S. Argov,et al. Human peritoneal mesothelial cells synthesize IL-1α and β , 1994 .
[82] M. Raftery,et al. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. , 1994, Kidney international.
[83] R. Clark,et al. Enhanced body growth in uremic rats treated with IGF-I and growth hormone in combination. , 1994, Kidney international.
[84] R. Alsop,et al. History, Chemical, and Pharmaceutical Development of Icodextrin , 1994 .
[85] H. Seo,et al. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. , 1994, The Journal of clinical investigation.
[86] J. Dobbie. Ultrastructure and pathology of the peritoneum in peritoneal dialysis , 1994 .
[87] N. Topley,et al. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[88] A. Wieslander,et al. Heat Sterilization of Fluids for Peritoneal Dialysis Gives Rise to Aldehydes , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[89] A. Wieslander,et al. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. , 1993, Clinical nephrology.
[90] J. Westwick,et al. Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. , 1993, The American journal of pathology.
[91] A. Donker,et al. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[92] T. Liberek,et al. Cell Function and Viability in Glucose Polymer Peritoneal Dialysis Fluids , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[93] W. Luttmann,et al. Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1β and TNFα , 1993 .
[94] A. Wieslander,et al. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. , 1991, Kidney international.
[95] E. Stylianou,et al. Isolation, culture and characterization of human peritoneal mesothelial cells. , 1990, Kidney international.
[96] T. Kooistra,et al. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. , 1990, Blood.
[97] Lloyd Jk,et al. Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. , 1990 .
[98] G. Sacchi,et al. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis (CAPD): an in vivo model for the study of diabetic microangiopathy. , 1989 .
[99] R. Gokal,et al. ULTRAFILTRATION WITH AN ISOSMOTIC SOLUTION DURING LONG PERITONEAL DIALYSIS EXCHANGES , 1987, The Lancet.
[100] T. Strom,et al. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. , 1986, Journal of immunology.
[101] P. Schollmeyer,et al. Prostaglandin-mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. , 1986, Kidney international.
[102] E. Jenkins,et al. Letter: Differential sister-chromatid staining. , 1975, Lancet.